Loading...

We are the Peptide Experts


JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.


Custom Peptide Synthesis


Product Finder

Search by scientific field

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

NEW: PepMix Collections for SARS-CoV-2 Wuhan & Variants

We now announce the launch of our PepMix Collections for SARS-CoV-2, which cover all revelant antigens of either structural or non-structural viral proteins or spike gylcoproteins belonging to so-far nine identified variants of concern.

Learn More

June 2022
Our Peptides in Action: Recent Publications in Oncology!
Since many years now, the focus in cancer research has shifted towards underlying immunological factors. Here, we demonstrate the range of our catalog and customizable products on the basis of recent publications that may be relevant for your research.
June 2022
We will be at the FOCIS in San Francisco!
We will be attending the 22nd annual meeting of the Federation of Clinical Immunology Societies (FOCIS) in San Francisco at the SF Marriott Marquis! Set up a meeting with our representatives beforehand or just find us at our booth!

June 2022

Check our list of products, click and go.

Get a quote